- Home
- XPON vs MTEM Comparison
XPON vs MTEM Comparison
Compare XPON & MTEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPON
- MTEM
- Stock Information
- Founded
- XPON 2016
- MTEM 2001
- Country
- XPON United States
- MTEM United States
- Employees
- XPON N/A
- MTEM N/A
- Industry
- XPON Electronic Components
- MTEM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- XPON Technology
- MTEM Health Care
- Exchange
- XPON Nasdaq
- MTEM Nasdaq
- Market Cap
- XPON 1.8M
- MTEM 9.7M
- IPO Year
- XPON 2022
- MTEM N/A
- Fundamental
- Price
- XPON $3.27
- MTEM $0.71
- Analyst Decision
- XPON
- MTEM
- Analyst Count
- XPON 0
- MTEM 0
- Target Price
- XPON N/A
- MTEM N/A
- AVG Volume (30 Days)
- XPON 3.1M
- MTEM 13.4M
- Earning Date
- XPON 11-07-2024
- MTEM 11-11-2024
- Dividend Yield
- XPON N/A
- MTEM N/A
- EPS Growth
- XPON N/A
- MTEM N/A
- EPS
- XPON N/A
- MTEM N/A
- Revenue
- XPON $4,998,801.00
- MTEM $25,470,000.00
- Revenue This Year
- XPON $0.68
- MTEM N/A
- Revenue Next Year
- XPON $29.04
- MTEM N/A
- P/E Ratio
- XPON N/A
- MTEM N/A
- Revenue Growth
- XPON N/A
- MTEM N/A
- 52 Week Low
- XPON $2.09
- MTEM $0.30
- 52 Week High
- XPON $639.00
- MTEM $6.48
- Technical
- Relative Strength Index (RSI)
- XPON 37.66
- MTEM 38.68
- Support Level
- XPON $2.70
- MTEM $0.31
- Resistance Level
- XPON $4.29
- MTEM $1.34
- Average True Range (ATR)
- XPON 0.77
- MTEM 0.14
- MACD
- XPON 0.50
- MTEM -0.05
- Stochastic Oscillator
- XPON 33.62
- MTEM 34.48
About XPON Expion360 Inc.
Expion360 Inc is focused on the design, assembly, manufacturing and sales of lithium iron phosphate (LiFePO4) batteries and supporting accessories for recreational vehicles ("RV's") and marine applications with plans to expand into home energy storage products and industrial applications. Its product offerings include some of the minimal-footprint batteries in the RV & Marine industry.
About MTEM Molecular Templates Inc.
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.